Biocon, one of India’s leading biopharmaceutical companies, has named Peter Bains as its Group CEO. Bains, an industry veteran with a successful track record, will be responsible for overseeing the company’s diverse portfolio, including biosimilars, research, and innovation. His appointment comes as Biocon seeks to strengthen its global presence and enhance its commitment to cutting-edge research in the biotechnology sector. With extensive experience in the healthcare industry, Bains is expected to drive strategic growth initiatives and foster collaborations to advance Biocon’s position as a key player in the biopharmaceutical market. This decision underscores Biocon’s dedication to leadership development and its pursuit of excellence in delivering life-saving therapies and innovative healthcare solutions.